Nutex Health Inc.
Nutex Health is a physician-led healthcare services and operations company headquartered in Houston, Texas. It operates three segments: a hospital division, a population health management division and a real estate division. As of December 31, 2025, the hospital division owns and operates 26 facilities in 12 states, including micro-hospitals, specialty hospitals and hospital outpatient departments. These facilities provide emergency and inpatient care, behavioral health and ancillary services such as imaging, laboratory and pharmacy services. The population health management division establishes and manages provider networks, including independent physician associations (IPAs), through its management services organization. The IPAs enroll patients and contract with insurers, while Nutex receives monthly capitated payments and management fees. The hospital division receives payments for facility services from federal agencies, private insurers and patients. The real estate division owns hospital properties that it leases to hospital entities; Nutex also owns its headquarters building.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $NUTX in the last 7 days.
No SEC Form 4 filings for $NUTX in the last 30 days.
See all $NUTX insider activity →Nutex Health (NASDAQ: NUTX) will host its Q3 2026 earnings call on Nov. 6, 2026, at 9:30 a.m. CT. The company will discuss financial performance and provide a business update. A transcript and recording will be available post-event on its website. Nutex operates 28 healthcare facilities across 12 states.
Nutex Health (NUTX) and Elevance Health (ELV) have outperformed the healthcare sector in 2026, with NUTX up 36% and ELV up 11%. NUTX trades at a P/E of 9, while ELV is at 18, both below the sector average of 29.75. NUTX reported strong earnings growth, and ELV reaffirmed its 2026 guidance, highlighting stabilization in its cost structure.
Nutex Health (NASDAQ: NUTX) received approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin September 23, 2026. The company will maintain its listing on the Nasdaq Global Market under the same ticker symbol, NUTX. The dual listing aims to increase visibility among regional investors while keeping its national and international presence.
Recent NUTX coverage spans earnings, financial news and corporate actions.
The call announcement provides a timing cue but contains no new financial data; price impact is expected to be minimal until results are released.
The article notes strong recent performance and valuation headroom, suggesting modest upside potential.
Dual‑listing may improve visibility and liquidity among regional investors, potentially supporting the stock price.
The breach update adds modest risk but no immediate financial impact; price likely to stay range‑bound.
The breach could lead to litigation costs, regulatory scrutiny, and potential stock volatility.
AlphAI scores every news story that mentions NUTX with an AI model for sentiment and relevance, and aggregates insider trades from Nutex Health Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Nutex Health (NASDAQ: NUTX) will host its Q3 2026 earnings call on Nov. 6, 2026, at 9:30 a.m. CT. The company will discuss financial performance and provide a business update. A transcript and recording will be available post-event on its website. Nutex operates 28 healthcare facilities across 12 states.
1 min readNutex Health (NUTX) and Elevance Health (ELV) have outperformed the healthcare sector in 2026, with NUTX up 36% and ELV up 11%. NUTX trades at a P/E of 9, while ELV is at 18, both below the sector average of 29.75. NUTX reported strong earnings growth, and ELV reaffirmed its 2026 guidance, highlighting stabilization in its cost structure.
2 min readNutex Health (NASDAQ: NUTX) received approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin September 23, 2026. The company will maintain its listing on the Nasdaq Global Market under the same ticker symbol, NUTX. The dual listing aims to increase visibility among regional investors while keeping its national and international presence.
1 min readNutex Health (NASDAQ: NUTX) updated stakeholders on a cybersecurity event, noting that stolen data was published online. The company is analyzing the data and has not yet identified material impacts on operations or financial reporting. Several lawsuits have been filed, but the company cannot predict outcomes or estimate financial impacts. Nutex operates 28 hospital facilities across 12 states.
1 min readNutex Health Inc. (NUTX) filed an SEC Form 8-K — Other Events. NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT HOUSTON, TX − (PRNewswire) –SEPTEMBER 10, 2026 – Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), today provided an update regarding its previously announced cyber security event. Nutex Health is a phys
2 min readZacks.com highlighted four companies with strong net profit margins: Nutex Health (NUTX), RCM Technologies (RCMT), Remitly Global (RELY), and Belden (BDC). Each company's 2026 earnings estimates were revised upward, with NUTX up 32.5%, RCMT up 13.3%, RELY up 13.8%, and BDC up 5.7%. All companies recently beat earnings estimates.
2 min readNutex Health (NASDAQ: NUTX) commented on a Fifth Circuit ruling invalidating federal QPA calculation rules under the No Surprises Act, which the company says artificially deflated payments. The court ruled insurers cannot include non-negotiated 'ghost rates' and must include bonus payments in QPA calculations. Nutex Health expects this to lead to fairer upfront payments for providers. The ruling may impact the company's financials, but the timeline for new regulations is uncertain.
2 min readNutex Health Inc. (NASDAQ: NUTX) opened its 28th hospital, West Little Rock Emergency Hospital, and its third Arkansas facility. The 18,966-square-foot site at 17810 Chenal Parkway has eight ER beds, five inpatient suites, two triage rooms, and full lab and imaging (MRI, CT, X-ray, ultrasound).
3 min readNutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.
7 min readNutex Health (NUTX) reported Q2 2026 results, with net income of $65.8M and diluted EPS of $9.38, versus a net loss of $17.7M a year earlier. Revenue fell 13.6% to $210.8M. The company cited IDR-related cost reductions, including a $52.3M contract services expense decline, and expects normalized historical expenses to drop 25% to 30% prospectively. Shares rose 14.88% to $186.19.
4 min read
